Literature DB >> 19653267

Analysis of unstirred water layer in in vitro permeability experiments.

Timo Korjamo1, Aki T Heikkinen, Jukka Mönkkönen.   

Abstract

In vitro permeability experiments are used widely in drug discovery and other areas of pharmaceutical research. Much effort has been expended in developing novel epithelial models but generally much less attention has been paid to the hydrodynamic barrier in the actual experiments. The restricted liquid flow in the vicinity of solid surfaces leads to a zone where the diffusional movement of molecules exceeds the convection. This leads to formation of a concentration gradient between the bulk solution and the surface. The formed unstirred water layer (UWL) reduces the apparent permeability (P(app)) of compounds that rapidly pass through the actual epithelial layer. This lowers the resolution of P(app) versus fraction-absorbed assay, complicates the structure-permeability analysis and skews apparent kinetic parameters of transporter substrates. This review describes the techniques that can be used to determine the UWL thickness in permeability experiments and apparatuses described in the literature to control the in vitro hydrodynamics. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653267     DOI: 10.1002/jps.21762

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  A reaction-diffusion model of CO2 influx into an oocyte.

Authors:  Erkki Somersalo; Rossana Occhipinti; Walter F Boron; Daniela Calvetti
Journal:  J Theor Biol       Date:  2012-06-20       Impact factor: 2.691

2.  Confocal imaging to quantify passive transport across biomimetic lipid membranes.

Authors:  Su Li; Peichi Hu; Noah Malmstadt
Journal:  Anal Chem       Date:  2010-09-15       Impact factor: 6.986

3.  Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.

Authors:  Alyscia Cory Severance; Philip J Sandoval; Stephen H Wright
Journal:  J Pharmacol Exp Ther       Date:  2017-06-14       Impact factor: 4.030

4.  In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.

Authors:  Alys E Davies; Rachel L Williams; Gaia Lugano; Serban R Pop; Victoria R Kearns
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

5.  Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.

Authors:  Yuan Li; Xueying Sun; Houfu Liu; Liang Huang; Guofeng Meng; Yu Ding; Wenji Su; Jiaqi Lu; Sophie Gong; Georg C Terstappen; Ru Zhang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2019-05-11       Impact factor: 5.203

6.  Unstirred Water Layers and the Kinetics of Organic Cation Transport.

Authors:  Takahiro Shibayama; Mark Morales; Xiaohong Zhang; Lucy J Martínez-Guerrero; Alfred Berteloot; Timothy W Secomb; Stephen H Wright
Journal:  Pharm Res       Date:  2015-03-20       Impact factor: 4.200

7.  Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.

Authors:  Zhiwen Yang; Yinhe Tan; Meiwan Chen; Linghui Dian; Ziyun Shan; Xinsheng Peng; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

8.  Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.

Authors:  Toshiaki Makino; Misaki Kanemaru; Shuji Okuyama; Ryosuke Shimizu; Hisashi Tanaka; Hajime Mizukami
Journal:  J Nat Med       Date:  2013-03-14       Impact factor: 2.343

Review 9.  Intestinal barrier function in health and gastrointestinal disease.

Authors:  M Camilleri; K Madsen; R Spiller; B Greenwood-Van Meerveld; B G Van Meerveld; G N Verne
Journal:  Neurogastroenterol Motil       Date:  2012-06       Impact factor: 3.598

10.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.

Authors:  Jie Lai; Yi Lu; Zongning Yin; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2010-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.